The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.
The latest on manufacturing and potential treatments for COVID-19 with news from J&J, Inovio, Novavax, Endo International, and the Serum Institute of India.
J&J Reports Positive Phase I/IIa Results for its COVID-19 Vaccine Johnson &...
Bayer has announced additional cost-cutting measures of EUR 1.5 billion ($1.76 billion) by 2024 to address headwinds encountered in its crop sciences and pharmaceutical businesses that were attenuated by the COVID-19 pandemic.The additional...
Belén Garijo, currently Deputy Chief Executive Officer (CEO), CEO Healthcare, and Vice Chair of the Executive Board of Merck KGaA, has been named as the company’s new Chair of the Executive Board and CEO, effective May 1, 2021.
Stefan Oschmann,...
Roche has acquired Inflazome, a Dublin, Ireland-based company developing inflammasome inhibitors for treating chronic inflammatory diseases, for EUR 380 million ($443 million) with Inflazome shareholders also eligible to receive additional...
Pfizer has entered into a manufacturing agreement with Vivet Therapeutics, a Paris-based gene-therapy company developing treatments for inherited liver disorders, under which Pfizer will provide clinical supply for a Phase I/II clinical trial...
Boehringer Ingelheim (BI) and Click Therapeutics, a New York-based developer of software as prescription medical treatments, have formed a collaboration, worth up more than $500 million, for the development and commercialization of a...
The latest on manufacturing and potential treatments for COVID-19 with news from J&J, Moderna, Fujifilm, Sinovac, the European Medicines Agency, Gavi, and others.
J&J Initiates Global Phase III Trial of COVID-19 Vaccine CandidateJohnson...
Sanofi and GlaxoSmithKline (GSK) have signed separate agreements with the European Commission (EC) and the Canadian government for the supply of their COVID-19 vaccine. The vaccine is based on the recombinant protein-based technology used by Sanofi...
BioNTech, a Mainz, Germany-based immunotherapy company, which is partnered with Pfizer for the development of a COVID-19 vaccine, has signed a purchase agreement with Novartis to acquire Novartis’ manufacturing facility in Marburg, Germany to...
The latest on manufacturing and potential treatments for COVID-19 with news from Eli Lilly and Company, Amgen, Regeneron, Google, and Vaxart.
Amgen, Lilly in Mfg Pact for COVID-19 Antibody TherapiesAmgen and Eli Lilly and Company have entered into...
Valneva, a Saint-Herblain, France-headquartered vaccine company, has entered into an agreement with the UK government to provide up to 190 million doses of its COVID-19 vaccine candidate, VLA2001, over a five-year period, in a deal worth up to $1.6...
Novavax, a Gaithersburg, Maryland-based clinical-stage vaccine company, has amended a previous agreement with the Serum Institute of India (SII), a Pune, Maharashtra, India-based vaccine manufacturer, under which SII will produce the antigen...
Takeda has opened a new 24,000-square-foot R&D and clinical cell-therapy manufacturing facility at its R&D headquarters in Boston, Massachusetts.
The facility will produce cell therapies for clinical evaluation from discovery through Phase...
Mylan and Pfizer have received final approval from the European Commission (EC) for their proposed combination of Mylan and Upjohn, Pfizer’s off-patent branded and generic established medicines business. The companies had announced the planned...
AstraZeneca reports that clinical trials for its COVID-19 vaccine, AZD1222, have resumed in the UK following confirmation by the UK pharmaceutical regulatory authority, the Medicines Health Regulatory Authority (MHRA), that it was safe to do so...
